Calliditas Therapeutics AB Cash Flow Statement 2019-2024 | CALT

Fifteen years of historical annual cash flow statements for Calliditas Therapeutics AB (CALT).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-35.18$-41.81$-61.15$-41.39$-2.96
$4.59$0$0$0$0.19
$-0.74$2.93$7.15$1.85$0.12
$3.86$2.93$7.15$1.85$0.31
$0$0$0$0$0
$-1.58$-0.27$-0.11$0$0
$0$0$0$0$0
$-5.94$9.04$0.75$5.90$-4.86
$-7.52$8.76$0.64$5.90$-4.86
$-40.99$-30.86$-53.82$-33.70$-7.51
$-1.21$-0.25$-0.77$0$-0.01
$0$0$-1.87$0$-1.70
$0$0$0$-18.81$0
$0$0$0$0$0
$-0.09$-0.26$-0.20$0.00$-0.20
$-0.09$-0.26$-0.20$0.00$-0.20
$0$0$0$0$0
$-1.30$-0.51$-2.84$-18.81$-1.91
$90.80$48.73$23.26$0$0
$-69.46$-0.95$-0.65$-0.43$-0.17
$21.34$47.78$22.61$-0.43$-0.17
$0$9.43$37.78$104$22.25
$0$9.43$37.78$104$22.25
$0$0$0$0$0
$-2.51$-0.12$-9.65$-19.41$-1.04
$18.83$57.08$50.74$83.77$21.04
$-25.97$29.09$-4.76$26.46$11.36
$4.96$0$0$0$0.03
$0$0$0$0$0